NCT04105270: RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial
- State
- Under way
- Phase
- Phase 2
- People
- 82 planned
- Started
- 30 Nov 2022
- Primary completion
- Jan 2028
- Arms
- Arm B (Placebo)
- Results
- None posted
- 26 Sep 2019: Trial registered
- 30 Nov 2022: Trial started